MARKET CLOSE: NZ shares rise as vaccine news spurs optimism

MARKET CLOSE: NZ shares rise as vaccine news spurs optimism
Dan Brunskill
New Zealand shares rose as promising results from a covid-19 vaccine trial spurred optimistic investors to take positions in riskier stocks. Kathmandu Holdings led the market higher. The S&P/NZX 50 Index advanced 152.25 points, or 1.3 percent, to 11,502.52. Within the index, 33 stocks rose, 12 fell, and five unchanged. Turnover was $156 million. Markets across Asia followed Wall Street higher as investors became optimistic after positive news about a potential vaccine for covid-19 emerged overnight. Stephen Innes, chief global market s...

More Markets

US tariff risk less than expected for FPH, Jarden says
Economy

US tariff risk less than expected for FPH, Jarden says

Jarden says tariff-related impacts on earnings would be "nominal" by 2030.

Jarden says Skellerup 'most exposed' to Trump's tariffs
Markets

Jarden says Skellerup 'most exposed' to Trump's tariffs

US President Donald Trump's sweeping global tariffs, announced on Thursday, are expected to have devastating consequences not only in the US but also in New Zealand.In a note on Friday morning, Jarden analysts Guy Hooper and Nick Yeo predicted that NZX-listed Skellerup looks...

Wall Street reels as Trump’s plan sinks markets
Markets

Wall Street reels as Trump’s plan sinks markets

The president’s sweeping tariffs proved far more severe than investors predicted.

Iron sand project could deliver $265m GDP boost: NZIER
Economy

Iron sand project could deliver $265m GDP boost: NZIER

Iron sands mining in Taranaki could create 1365 jobs, NZIER report says.